Evidence map›Paper›PMID 35273216›Full record

ArticleScientific reports2022

Novel indolic AMPK modulators induce vasodilatation through activation of the AMPK-eNOS-NO pathway.

Marta Sanz-Gómez, Elnaz Aledavood, Marina Beroiz-Salaverri, Laura Lagartera, Elena Vega-Martín, Marta Gil-Ortega, Jose Cumella, Concepción Pérez, Francisco Javier Luque, Carolina Estarellas and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Marta Sanz-Gómez *Instituto Pluridisciplinar and Facultad de Farmacia, Universidad Complutense de Madrid, Madrid, Spain.
Elnaz Aledavood *Departamento de Nutrición, Ciencias de la Alimentación y Gastronomía, Facultad de Farmacia y Ciencias de la Alimentación, Instituto de Biomedicina (IBUB) e Instituto de Química Teórica y Computacional (ICTQBUB), Universidad de Barcelona, Campus Torribera, Santa Coloma de Gramenet, Spain.
Marina Beroiz-SalaverriInstituto Pluridisciplinar and Facultad de Farmacia, Universidad Complutense de Madrid, Madrid, Spain.
Laura LagarteraInstituto de Química Médica, IQM-CSIC, Madrid, Spain.
Elena Vega-MartínInstituto Pluridisciplinar and Facultad de Farmacia, Universidad Complutense de Madrid, Madrid, Spain.
Marta Gil-OrtegaDepartamento de Ciencias Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU, Madrid, Spain.
Jose CumellaInstituto de Química Médica, IQM-CSIC, Madrid, Spain.
Concepción PérezInstituto de Química Médica, IQM-CSIC, Madrid, Spain.
Francisco Javier LuqueDepartamento de Nutrición, Ciencias de la Alimentación y Gastronomía, Facultad de Farmacia y Ciencias de la Alimentación, Instituto de Biomedicina (IBUB) e Instituto de Química Teórica y Computacional (ICTQBUB), Universidad de Barcelona, Campus Torribera, Santa Coloma de Gramenet, Spain.
Carolina EstarellasDepartamento de Nutrición, Ciencias de la Alimentación y Gastronomía, Facultad de Farmacia y Ciencias de la Alimentación, Instituto de Biomedicina (IBUB) e Instituto de Química Teórica y Computacional (ICTQBUB), Universidad de Barcelona, Campus Torribera, Santa Coloma de Gramenet, Spain. cestarellas@ub.edu.
María S Fernández-AlfonsoInstituto Pluridisciplinar and Facultad de Farmacia, Universidad Complutense de Madrid, Madrid, Spain. marisolf@ucm.es.
Ana CastroInstituto de Química Médica, IQM-CSIC, Madrid, Spain. acastro@iqm.csic.es.
Instituto de Química Médica · ESUniversidad Complutense de Madrid · ESUniversitat de Barcelona · ESUniversidad San Pablo CEU · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endothelial adenosine monophosphate-activated protein kinase (AMPK) plays a critical role in the regulation of vascular tone through stimulating nitric oxide (NO) release in endothelial cells. Since obesity leads to endothelial dysfunction and AMPK dysregulation, AMPK activation might be an important strategy to restore vascular function in cardiometabolic alterations. Here, we report the identification of a novel AMPK modulator, the indolic derivative IND6, which shows affinity for AMPKα1β1γ1, the primary AMPK isoform in human EA.Hy926 endothelial cells. IND6 shows inhibitory action of the enzymatic activity in vitro, but increases the levels of p-Thr

Indexed as

AMP-Activated Protein KinasesVasodilationAnimalsEndothelial CellsEndothelium, VascularHumansNitric OxideNitric Oxide Synthase Type IIIObesityPhosphorylationRatsSignal TransductionAMP-Activated Protein KinasesNitric OxideNitric Oxide Synthase Type III

Identifiers

PMID35273216
PMCPMC8913687
OpenAlexW4220838777

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.